Indivior PLC INVVY
Set alert
21.85 0.00 0.00%
As of Jun 9, 10:23 AM ET
21.85 Day range 21.85
14.76 52-week range 75.65
- Open
- 21.65
- Prev close
- 21.85
- Mkt cap
- 3.01B
- Vol
- 8.10K
- Avg vol
- 3.71K
- EPS
- -0.35
- P/E
- -62.42
More statistics
- Low
- 21.85
- High
- 21.85
- Earnings
- Jun 15, 2023
Next earnings
Jun 15, 2023
Expected Jun 15, 2023. Consensus EPS estimate 0.00.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Jun 15, 2023 | Mar 1, 2023 | 0.00 | — | — | — |
| Jan 4, 2023 | Sep 1, 2022 | 0.00 | — | — | — |
| Jul 28, 2022 | Jun 1, 2022 | 0.00 | — | — | — |
| Apr 28, 2022 | Mar 1, 2022 | 0.00 | — | — | — |
| Feb 16, 2022 | Dec 1, 2021 | 0.00 | — | — | — |
News
- Indivior Reports Third Quarter 2026 Financial Results
- Indivior to Report Third Quarter 2026 Financial Results
- Addex Regains Rights to GABAB Positive Allosteric Modulator Portfolio from Indivior
- Indivior Pharmaceuticals, Inc. Declares Special Cash Dividend
- INDV Stock Alert: Halper Sadeh LLC is Investigating Whether Indivior Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders
- Indivior's Supernus Merger Could Broaden Its Growth Engine in 2026
- Indivior (OTCMKTS:INVVY) Share Price Passes Below Two Hundred Day Moving Average – Should You Sell?
- Supernus to Combine with Indivior To Form CNS Biopharmaceutical Leader with Potential $2 Billion in Revenue
- INDV Stock Alert: Halper Sadeh LLC is Investigating Whether Indivior Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders
- Indivior Pharmaceuticals Inc. (INDV) Q2 Earnings and Revenues Beat Estimates
Your note
Sign in to keep a note on INVVY — it syncs with the Stock Master app.